Strategic partnerships The Gates MRI actively collaborates with global partners (e.g., Serum Institute of India, Adimab, SK Bioscience) to advance vaccines and monoclonal antibody candidates, indicating readiness to engage via licensing, co-development, or manufacturing partnerships that align with global health priorities.

Contract manufacturing Recent manufacturing partnerships for TB vaccine candidates suggest Gates MRI could be a buyer or collaborator for scale-up services, cGMP manufacturing, and supply chain support for high-priority vaccines in TB, RSV, and related infectious diseases.

Monoclonal antibodies Active development and licensing of RSV monoclonal antibody candidates signals a sales opportunity for biopharma CDMO services, licensing negotiations, technology transfer, and distribution partnerships across lower- and middle-income markets.

Global health focus With a mission driven by TB, malaria, diarrheal diseases, and maternal-child health, there is potential to offer grant-aligned research services, regulatory support, and access-focused product development solutions to accelerate programs aligned with Gates Foundation priorities.

Non-profit collaboration As a Gates Foundation affiliate with significant revenue and a lean-to-mid sized team, Gates MRI represents a profile that seeks mission-aligned suppliers and partners that can provide flexible funding models, rapid regulatory interactions, and impact-driven timelines for global health interventions.